Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, octobre 23
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Bausch Health Companies Inc
BHC
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$6.44
-0.05
-0.77%
Dern. MÀJ: Oct 23, 4:00 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Résultats:
Résultats Q3 2026 dans dans 5 jours à partir de maintenant le mer. oct. 28th, après la fermeture du marché
Conférence téléphonique:
Conférence téléphonique prévue dans 5 jours à 5:00 PM
Cliquez pour voir la webdiffusion
Bausch Health Companies Financials
Bausch Health Companies (BHC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Why Is Bausch + Lomb Stock Falling Monday?
Bausch + Lomb stock drops 10% following sudden CEO departure, despite raising full-year 2026 EBITDA guidance.
Neeraj Jain
PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est
Bausch Health Companies (TSX:BHC) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.
Benzinga Newsdesk
PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.04 Estimate, Sales $2.852B Beat $2.661B Estimate
Benzinga Newsdesk
PRO
Bausch Health Companies Q2 Adj. EPS $1.26 Beats $1.06 Estimate, Sales $2.852B Beat $2.679B Estimate
Bausch Health Companies (TSX:BHC) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.06 by 17.76 percent. This is a 38.46 percent increase over earnings of $0.91 per share
Benzinga Newsdesk
PRO
Bausch Health Companies Raises FY2026 Sales Guidance from $10.625B-$10.875B to $10.670B-$10.920B vs $10.595B Est
Bausch Health Companies (NYSE:BHC) raises FY2026 sales outlook from $10.625 billion-$10.875 billion to $10.670 billion-$10.920 billion vs $10.595 billion estimate.
Benzinga Newsdesk
PRO
Bausch Health Companies Q1 Adj. EPS $0.78 Beats $0.69 Estimate, Sales $2.524B Beat $2.409B Estimate
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.69 by 13.04 percent. This is a 27.87 percent increase over earnings of $0.61 per share
Benzinga Newsdesk
